Inhaled epoprostenol compared with nitric oxide for right ventricular support after major cardiac surgery

K Ghadimi, JL Cappiello, MC Wright, JH Levy… - Circulation, 2023 - Am Heart Assoc
BACKGROUND: Right ventricular failure (RVF) is a leading driver of morbidity and death
after major cardiac surgery for advanced heart failure, including orthotopic heart …

Inhaled nitric oxide in cardiac surgery: evidence or tradition?

M Benedetto, R Romano, G Baca, D Sarridou… - Nitric Oxide, 2015 - Elsevier
Inhaled nitric oxide (iNO) therapy as a selective pulmonary vasodilator in cardiac surgery
has been one of the most significant pharmacological advances in managing pulmonary …

Evaluation of a heart transplant candidate

SJ Lee, KH Kim, SK Hong, S Hankins - Current cardiology reports, 2017 - Springer
Abstract Purpose of Review Heart transplantation is the best option for irreversible and
critically advanced heart failure. However, limited donor pool, the risk of rejection, infection …

Canadian Cardiovascular Society/Canadian Cardiac Transplant Network position statement on heart transplantation: patient eligibility, selection, and post …

S Chih, M McDonald, A Dipchand, D Kim… - Canadian Journal of …, 2020 - Elsevier
Significant practice-changing developments have occurred in the care of heart
transplantation candidates and recipients over the past decade. This Canadian …

Have risk factors for mortality after heart transplantation changed over time? Insights from 19 years of Cardiac Transplant Research Database study

JA Tallaj, SV Pamboukian, JF George, JK Kirklin… - The Journal of Heart and …, 2014 - Elsevier
Background The Cardiac Transplant Research Database (CTRD) collected data from 26 US
institutions from January 1, 1990 to December 31, 2008 providing the opportunity for …

Left ventricular dysfunction with pulmonary hypertension: part 2: prognosis, noninvasive evaluation, treatment, and future research

AP Kalogeropoulos, VV Georgiopoulou… - Circulation: Heart …, 2013 - Am Heart Assoc
Kalogeropoulos et al Group 2 PH, Part 2 585 enrollment, was not associated with worse 6-
month outcomes. In contrast, in the VMAC (Vasodilation in the Management of Acute …

Induction of right ventricular failure by pulmonary artery constriction and evaluation of right ventricular function in mice

Q Wang, K Chen, H Lin, M He, X Huang, H Zhu… - JoVE (Journal of …, 2019 - jove.com
The mechanism of right ventricular failure (RVF) requires clarification due to the uniqueness,
high morbidity, high mortality, and refractory nature of RVF. Previous rat models imitating …

Pathophysiology and potential treatments of pulmonary hypertension due to systolic left heart failure

J Lundgren, G Rådegran - Acta Physiologica, 2014 - Wiley Online Library
Pulmonary hypertension (PH) due to left heart failure is becoming increasingly prevalent
and is associated with poor outcome. The precise pathophysiological mechanisms behind …

Non-sexual implications of phosphodiesterase type 5 inhibitors

T Mostafa - Sexual Medicine Reviews, 2017 - academic.oup.com
Abstract Introduction Phosphodiesterase type 5 (PDE5) hydrolyses cyclic guanylate
monophosphate specifically to 5′ guanylate monophosphate, promoting corporeal …

Preoperative pulmonary hypertension and its impact on survival after heart transplantation

J Lundgren, L Algotsson, B Kornhall… - Scandinavian …, 2014 - Taylor & Francis
Objectives. Pulmonary hypertension (PH) due to left heart disease may impair outcome after
heart transplantation (HT). To evaluate to what extent previous, and present, haemodynamic …